Your browser doesn't support javascript.
loading
Personalized Biomarker-Based Umbrella Trial for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: KCSG HN 15-16 TRIUMPH Trial.
Keam, Bhumsuk; Hong, Min Hee; Shin, Seong Hoon; Heo, Seong Gu; Kim, Ji Eun; Ahn, Hee Kyung; Lee, Yun-Gyoo; Park, Keon-Uk; Yun, Tak; Lee, Keun-Wook; Kim, Sung-Bae; Lee, Sang-Cheol; Kim, Min Kyoung; Cho, Sang Hee; Oh, So Yeon; Park, Sang-Gon; Hwang, Shinwon; Nam, Byung-Ho; Kim, Sangwoo; Kim, Hye Ryun; Yun, Hwan Jung.
Afiliação
  • Keam B; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Hong MH; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Shin SH; Divison of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Heo SG; Department of Internal Medicine, Kosin University Gospel Hospital, Busan, Republic of Korea.
  • Kim JE; Yonsei Cancer Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Ahn HK; Division of Cancer Data Science, National Cancer Center, Goyang, Republic of Korea.
  • Lee YG; Department of Pathology, Seoul National University College of Medicine, SMG-SNU Boramae Hospital, Seoul, Republic of Korea.
  • Park KU; Division of Medical Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Republic of Korea.
  • Yun T; Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Lee KW; Department of Internal Medicine, Keimyung University Dongsan Hospital, Daegu, Republic of Korea.
  • Kim SB; Rare Cancers Clinic, Center for Specific Organs Cancer, National Cancer Center, Goyang, Republic of Korea.
  • Lee SC; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Kim MK; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Cho SH; Division of Hematology-Oncology, Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Republic of Korea.
  • Oh SY; Division of Hematology-Oncology, Department of Internal Medicine, Yeungnam University Hospital, Yeungnam University College of Medicine, Daegu, Republic of Korea.
  • Park SG; Department of Hemato-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Gwangju, Republic of Korea.
  • Hwang S; Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Republic of Korea.
  • Nam BH; Department of Hemato-Oncology, Chosun University Hospital, Gwangju, Republic of Korea.
  • Kim S; Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Kim HR; Department of Medicine, Physician-Scientist Program, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Yun HJ; HERINGS, Seoul, Republic of Korea.
J Clin Oncol ; 42(5): 507-517, 2024 Feb 10.
Article em En | MEDLINE | ID: mdl-37699162
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias de Cabeça e Pescoço / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias de Cabeça e Pescoço / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2024 Tipo de documento: Article